ArticleProceedings of the National Academy of Sciences of the United States of America2022

Precision targeting tumor cells using cancer-specific InDel mutations with CRISPR-Cas9.

Taejoon Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.